Evidence map›Paper›PMID 30560673›Full record

ArticleJournal of proteome research2019

Averaging Strategy To Reduce Variability in Target-Decoy Estimates of False Discovery Rate.

Uri Keich, Kaipo Tamura, William Stafford Noble

Abstract read
In one paragraph

Article in Journal of proteome research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Null-free False Discovery Rate Control Using Decoy Permutations.Acta mathematicae applicatae Sinica (English series) · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Uri KeichSchool of Mathematics and Statistics F07 , University of Sydney , Sydney , New South Wales 2006 , Australia.
Kaipo TamuraDepartment of Genome Sciences , University of Washington , Foege Building S220B, 3720 15th Avenue NE , Seattle , Washington 98195-5065 , United States.
William Stafford NobleDepartment of Genome Sciences , University of Washington , Foege Building S220B, 3720 15th Avenue NE , Seattle , Washington 98195-5065 , United States.ORCID 0000-0001-7283-4715

Funding

TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2012 to 2021
$20.7M
Optimization and joint modeling for peptide detection by tandem mass spectrometryR01GM121818 · NIGMS · UNIVERSITY OF WASHINGTON · PI NOBLE, WILLIAM STAFFORD · 2017 to 2020
$1.3M
NIGMS NIH HHS P41 GM103533NIGMS NIH HHS R01 GM121818
6 · The paper itself

Abstract

Decoy database search with target-decoy competition (TDC) provides an intuitive, easy-to-implement method for estimating the false discovery rate (FDR) associated with spectrum identifications from shotgun proteomics data. However, the procedure can yield different results for a fixed data set analyzed with different decoy databases, and this decoy-induced variability is particularly problematic for smaller FDR thresholds, data sets, or databases. The average TDC (aTDC) protocol combats this problem by exploiting multiple independently shuffled decoy databases to provide an FDR estimate with reduced variability. We provide a tutorial introduction to aTDC, describe an improved variant of the protocol that offers increased statistical power, and discuss how to deploy aTDC in practice using the Crux software toolkit.

Indexed as

SoftwareDatabases, ProteinDatasets as TopicHumansModels, StatisticalProteomicsReproducibility of Resultsfalse discovery ratemass spectrometryspectrum identification

Identifiers

PMID30560673
PMCPMC6919216

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.